We are live on ! Find out more

19 hedge funds and large institutions have $849K invested in DNA X in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

19% more funds holding

Funds holding: 16 → 19 (+3)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.02% less ownership

Funds ownership: 3.26% → 3.24% (-0.02%)

15% less capital inflows, than outflows

Capital inflows: $43.3K | Capital outflows: $50.8K

Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SONM Hedge Fund Activity: Q1 2024 in Review

19 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in DNA X (SONM) for Q1 2024, worth a combined $849K — down 18% from $1.03M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SONM positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Commonwealth Equity Services, opening a new position worth an estimated $33K. The largest seller was Renaissance Technologies, cutting an estimated $23.5K.

  • 19 institutional investors held DNA X (SONM) as of Q1 2024, up from 16 in Q4 2023.
  • Funds reported $849K of DNA X stock for Q1 2024, down 18% quarter-over-quarter.
  • 4 funds opened new DNA X positions in Q1 2024 and 1 closed out, a net change of +3 holders.
  • The largest DNA X buyer in Q1 2024 was Commonwealth Equity Services, an estimated $33K added.
  • The largest DNA X seller in Q1 2024 was Renaissance Technologies, an estimated $23.5K sold.

Based on aggregated 13F filings for Q1 2024.